Performance of the Human Papillomavirus E6/E7 mRNA Assay in the Primary Screening of Cervical Cancer: Opportunistic Screening in Fujian, China
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Women's Health"
DOI: 10.2147/ijwh.s383431
Abstract: Purpose A high-risk human papillomavirus E6/E7 mRNA (HR-HPV mRNA) assay is widely used in cervical cancer screening in China. However, it is still unclear whether stand-alone HR-HPV mRNA testing is sufficient for primary screening. The… read more here.
Keywords: cervical cancer; primary screening; hpv mrna; cytology ... See more keywords